Cannabis and the developing brain challenge risk perception.
Journal of Clinical Investigation June 22, 2020 DOI: 10.1172/jci139051 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Topics | Cannabis |
| Key points | Argues that increased cannabis availability, legalization, and highly modified strains with high THC and low CBD create unprecedented neurodevelopmental risks, particularly for vulnerable populations. |
Abstract
The past decade has seen a reduction in society’s perception of cannabis being of any risk or harm. However, we are in a transformational time in which cannabis’ health implications related to neurodevelopment, particularly for vulnerable populations, must challenge such perceptions of harmlessness. The combination of multiple interrelated factors — societal, political, and business — have created the “perfect cannabis storm” of unintended neurodevelopmental consequences with an unmatched exposure to cannabis compared with exposure levels never experienced before in human history. Increased exposure is driven by the drug’s increased availability across all levels of society. This is due to the legalization of cannabis in most states, coupled with the recent explosion of highly modified cannabis strains and extracted pure Δ9-tetrahydrocanabinol (THC), the prominent psychoactive cannabinoid from the plant. This explosion has led to diverse products consumed by numerous routes and with extremely high THC potencies. Thus, cannabis today is dramatically different from cannabis even ten years ago, with exponentially increased THC concentrations (1). At the same time, levels of other cannabinoids such as cannabidiol (CBD) that appear to have some protective properties are lower in the plant, leading to THC/CBD ratios of 104 in 2017 versus 23 in 2008 (1). While some turn to dispensaries for “safer” cannabinoids, these products can contain far greater THC content (~70%) than the cannabis [...] Viewpoint
Citations in the library
Cited by 6
- Pediatric Brain on Cannabinoids: Adverse Effects of Cannabinoid Products in Children and Adolescents IntechOpen eBooks August 3, 2022
- Same dose, different impact: acute cannabis intoxication impairs visuospatial working memory in both sexes, with disproportionate male vulnerability Frontiers in Behavioral Neuroscience April 16, 2026
- A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids. Frontiers in Psychiatry 2024
- Daily Δ9-Tetrahydrocannabinol and Withdrawal Increase Dopamine D1-D2 Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism. Biological Psychiatry Global Open Science July 2023
- Δ9-Tetrahydrocannabinol does not upregulate an aversive dopamine receptor mechanism in adolescent brain unlike in adults. Current Research in Neurobiology 2023
and 1 more in the library